MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Memory compensation strategies in patients with Parkinson’s disease

C.C. Walton, J.Y.Y. Szeto, L. Mowszowski, S.J.G. Lewis, S.L. Naismith (Sydney, Australia)

Meeting: 2016 International Congress

Abstract Number: 1355

Keywords: Memory disorders, Parkinsonism, Rehabilitation

Session Information

Date: Wednesday, June 22, 2016

Session Title: Cognitive disorders

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To investigate the use of memory compensation strategies in Parkinson’s disease.

Background: Difficulty with memory is a particular cause of complaint in patients with Parkinson’s disease (PD) and is a predictor of subsequent cognitive decline. Cognitive training is now a more commonly investigated nonpharmacological technique for alleviating cognitive deficits in PD. However, little is known about how patients independently recruit memory compensation strategies (MCS) in their daily lives. The current study aimed to investigate how commonly strategies are employed, and what predicts their use.

Methods: Patients were recruited through the PD Research Clinic at the University of Sydney. The Memory Compensations Questionnaire (MCQ) was used to measure strategy use. The 45-item questionnaire leads to scores in five scales representing strategy use: ‘Internal’ (use of internal strategies), ‘External’ (use of external strategies), ‘Recruitment’ (reliance on other people), ‘Effort’ (investment of effort into memory tasks) and ‘Time’ (investment of time into memory tasks). There are an additional two scales assessing compensation beliefs: ‘Change’ (observation of memory change in last 5-10 years) and ‘Success’ (commitment to high level of memory performance). Other typical clinical measures where obtained during the clinic assessment. We built three multiple regression models to predict external and internal strategy use, along with recruitment. All clinical variables which were significantly correlated with these MCS were entered at once into the respective model.

Results: Data for 81 patients was obtained. The sample was relatively high functioning. Patients prioritized external strategies above internal, and relied on friends and family least. Time, effort, change, and gender significantly accounted for 22.6% of the variance in external strategy use (F76,4 = 5.547, p < .001). Time, effort, success, change and depression scores significantly accounted for 54.6% of the variance in internal strategy use (F72,5 = 5.547, p < .001). Time, effort, success, change, gender, depression and memory scores accounted for 36.6% of the variance in external strategy use (F69,8 = 4.983, p < .001).

Conclusions: Preliminary data suggests MCS are used by non-demented patients with PD, although guidance may be needed in remediation programs, to increase internal strategy use. Future research is needed to investigate MCS in a more impaired sample.

To cite this abstract in AMA style:

C.C. Walton, J.Y.Y. Szeto, L. Mowszowski, S.J.G. Lewis, S.L. Naismith. Memory compensation strategies in patients with Parkinson’s disease [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/memory-compensation-strategies-in-patients-with-parkinsons-disease/. Accessed May 13, 2025.
  • Tweet
  • Email
  • Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/memory-compensation-strategies-in-patients-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley